Divestiture Strategy & Execution

Technology & Digital Services
Written By Matthew Schmucker

Overview

In the wake of a divisional sell-off, a top Fortune 50 pharmaceutical client partnered with eta one to create and execute upon a Divestiture Strategy for its Clinical, R&D, Quality, Safety and Medical Affairs systems. This included aligning Business and IT teams at both our client and the acquiring firm, in addition to working with the relevant software vendors for licensing, functionality and data migration needs.

Target

Develop and execute upon a Divestiture Strategy, which included more than 30 validated systems including Oracle Clinical, I.R.M.S., Trackwise, OpenQ, QUMAS, AEGIS and Oracle Argus.  The timeline required our client and the acquiring firm to mutually approve each system’s Transition/ Handover Document within a 12-month period.

  

Solution Delivery

To maintain effective traceability, eta one treated each system as a sub-project within the overall Divestiture program.  Every sub-project included the following planning efforts, which enabled a smooth execution:

  • Needs Analysis (including a User Assessment)

  • Data Migration Plan

  • Validation Plan

  • Change Management Plan

  • Metrics/Reporting Transition Plan

  • Cutover Plan

  • Project Plan



Results

Our client was able to cleanly divest each of its core systems to the acquiring firm, in a compliant and efficient way over the course of a 12-month period. 

Matthew Schmucker
Previous

Workflow Tool Assessment, Selection and Implementation (for Investigator Sponsored Research Proposals)